Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoxiang Shen

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Biopharmaceutics & Drug Disposition|September 3, 2009
Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transportersGuoxiang Shen, Ah-Ng Kong
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 24, 2007
Development and validation of an HPLC method for the determination of dibenzoylmethane in rat plasma and its application to the pharmacokinetic studyGuoxiang Shen, Jin-Liern Hong, Ah-Ng Tony Kong
Antioxidants & Redox Signaling|December 17, 2005
Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agentsGuoxiang Shen, Woo-Sik Jeong, Rong Hu, et al.
Cancer Chemotherapy and Pharmacology|September 20, 2005
p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1Guoxiang Shen, Changjiang Xu, Chi Chen, et al.
Oncogene|April 28, 2005
Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cellsChangjiang Xu, Guoxiang Shen, Chi Chen, et al.
Molecular Cancer Therapeutics|September 16, 2008
Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanismSiwang Yu, Guoxiang Shen, Tin Oo Khor, et al.
Carcinogenesis|June 24, 2003
Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cellsChi Chen, Guoxiang Shen, Vidya Hebbar, et al.
Journal of Chromatographic Science|November 15, 2011
Development and validation of an LC-MS-MS method for the simultaneous determination of sulforaphane and its metabolites in rat plasma and its application in pharmacokinetic studiesHu Wang, Wen Lin, Guoxiang Shen, et al.
Clinical Therapeutics|July 12, 2014
Pharmacokinetics and safety of subcutaneous pasireotide and intramuscular pasireotide long-acting release in Chinese male healthy volunteers: a phase I, single-center, open-label, randomized studyXia Chen, Guoxiang Shen, Ji Jiang, et al.
Archives of Pharmacal Research|November 24, 2006
In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the miceRong Hu, Guoxiang Shen, Usha Rao Yerramilli, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Biopharmaceutics & Drug Disposition|September 3, 2009
Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transportersGuoxiang Shen, Ah-Ng Kong
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 24, 2007
Development and validation of an HPLC method for the determination of dibenzoylmethane in rat plasma and its application to the pharmacokinetic studyGuoxiang Shen, Jin-Liern Hong, Ah-Ng Tony Kong
Antioxidants & Redox Signaling|December 17, 2005
Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agentsGuoxiang Shen, Woo-Sik Jeong, Rong Hu, et al.
Cancer Chemotherapy and Pharmacology|September 20, 2005
p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1Guoxiang Shen, Changjiang Xu, Chi Chen, et al.
Oncogene|April 28, 2005
Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cellsChangjiang Xu, Guoxiang Shen, Chi Chen, et al.
Molecular Cancer Therapeutics|September 16, 2008
Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanismSiwang Yu, Guoxiang Shen, Tin Oo Khor, et al.
Carcinogenesis|June 24, 2003
Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cellsChi Chen, Guoxiang Shen, Vidya Hebbar, et al.
Journal of Chromatographic Science|November 15, 2011
Development and validation of an LC-MS-MS method for the simultaneous determination of sulforaphane and its metabolites in rat plasma and its application in pharmacokinetic studiesHu Wang, Wen Lin, Guoxiang Shen, et al.
Clinical Therapeutics|July 12, 2014
Pharmacokinetics and safety of subcutaneous pasireotide and intramuscular pasireotide long-acting release in Chinese male healthy volunteers: a phase I, single-center, open-label, randomized studyXia Chen, Guoxiang Shen, Ji Jiang, et al.
Archives of Pharmacal Research|November 24, 2006
In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the miceRong Hu, Guoxiang Shen, Usha Rao Yerramilli, et al.
Pageof 5